Projects per year
Personal profile
External positions
Post-Doctoral Fellow, Institut Curie Paris, UMR 144 CNRS, Department of Cell Morphogenesis and Tumor progression
2000 → 2003
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Hi-ROC: Targeting hypoxia with heavy ions to gain control of radioresistant cancers
Janji, B. (PI) & Vogin, G. (CoPI)
FNR - Fonds National de la Recherche
1/03/25 → 29/02/28
Project: Research
-
CombiN (Elisabetta Bartolini): Improving the Therapeutic benefit of immunotherapy in Neuroblastoma by combining autophagy inhibitor and anti-PD-i
Janji, B. (PI) & Bartolini, E. (PhD Student)
1/02/23 → 31/01/27
Project: Research
-
LSCR 2027: Lecture Series in Cancer Research 2027
Janji, B. (PI), Meiser, J. (Partner) & von Kalle, C. (Partner)
FNR - Fonds National de la Recherche
1/01/27 → 31/12/27
Project: Research
-
Hypoxic Tumor Microenvironment Targeting: Opportunities and Challenges for Pancreatic Cancer Immunotherapy
Abou Khouzam, R., Salman, S., Thiery, J., Zaarour, R. F., Vela, V., Limani, P., Janji, B. & Chouaib, S., 27 Apr 2026, In: International Journal of Molecular Sciences. 27, 9, 33 p., 3873.Research output: Contribution to journal › Review article › peer-review
Open Access1 Citation (Scopus) -
VPS34 in Autophagy, Cancer, and Cancer Therapy
Bartolini, E., Janji, B. & Gao, R., 1 Apr 2026, In: Cells. 15, 7, 22 p., 636.Research output: Contribution to journal › Review article › peer-review
Open Access1 Citation (Scopus) -
Inter- and intra-tumoral ALDH1 heterogeneity in breast cancer identifies therapeutic opportunities for ALDH1A-specific inhibitors
Pequerul, R., Constantinescu, A., Janji, B., Kumar, A., Baier, C., Manosalva, I., Parés, X., Palacios, O., Spicuglia, S., Colignon, D., Berrou, A., Fournet, G., Berchard, P., Martin, G., Ceylan, I., Rebollido-Rios, R., Farrés, J. & Perez-Alea, M., 16 Oct 2025, In: Cell Chemical Biology. 32, 10, p. 1260-1278.e12 32 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus) -
Quantitative pre-clinical imaging of hypoxia and vascularity using MRI and PET
Kanli, G., Boudissa, S., Jirik, R., Adamsen, T., Espedal, H., Rolfsnes, H. O., Thorsen, F., Pacheco-Torres, J., Janji, B. & Keunen, O., 15 Jan 2025, Immuno-Oncology and Immunotherapy - Part C. Bloy, N., Charpentier, M. & Galluzzi, L. (eds.). Academic Press Inc., Vol. 191. p. 289-328 40 p. (Methods in Cell Biology; vol. 191).Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
7 Citations (Scopus) -
Targeting the atypical chemokine receptor 2 (Ackr2) improves the benefit of anti-PD-1 immunotherapy in melanoma mouse model
Noman, M. Z., Szpakowska, M., Xiao, M., Gao, R., Van Moer, K., Kumar, A., Ollert, M., Berchem, G., Chevigné, A. & Janji, B., 18 Apr 2025, In: OncoImmunology. 14, 1, 9 p., 2494426.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus)